AUGUST 18, 2023. By CATIE Prevention in Focus
Direct-acting antivirals (DAAs) cure hepatitis C, but a person can get hepatitis C again if they are exposed to the virus. This is called reinfection. Reinfections are a reality of hepatitis C work. CATIE talked to three people with expertise in hepatitis C reinfection and asked them to share their perspectives and experience related to working with people with hepatitis C reinfections, why it’s important for us to reframe our thinking about reinfections, and policy-related considerations.
- Professor Gregory Dore is the head of the Viral Hepatitis Clinical Research Program at the Kirby Institute located in the University of New South Wales (UNSW) in Sydney, Australia
- Bernadette Lettner is a hepatitis C treatment nurse with the Toronto Community Hep C Program
- Sofia Bartlett is a senior scientist for sexually transmitted and blood-borne infections (STBBIs) at the BC Centre for Disease Control and an adjunct professor in the School of Population and Public Health, University of British Columbia
Visit the CATIE Blog website for the full blog post.
